Healthcare provider profile · identity verified

Syed A Raza, MD

Internal Medicine · SALEM, VA · NPI 1326027301

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	341	64
Amlodipine Besylate	Amlodipine Besylate	243	56
Atorvastatin Calcium	Atorvastatin Calcium	234	54
Lisinopril	Lisinopril	232	61
Gabapentin	Gabapentin	210	36
Omeprazole	Omeprazole	210	42
Escitalopram Oxalate	Escitalopram Oxalate	156	37
Metformin Hcl	Metformin Hcl	143	34
Clonazepam	Clonazepam	125	12
Famotidine	Famotidine	120	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	120	16
Furosemide	Furosemide	118	28
Losartan Potassium	Losartan Potassium	118	32
Oxycodone Hcl	Oxycodone Hcl	117	17
Rosuvastatin Calcium	Rosuvastatin Calcium	117	32
Eliquis	Apixaban	115	24
Tramadol Hcl	Tramadol Hcl	108	26
Simvastatin	Simvastatin	105	24
Trazodone Hcl	Trazodone Hcl	104	26
Metoprolol Tartrate	Metoprolol Tartrate	103	23
Tamsulosin Hcl	Tamsulosin Hcl	97	28
Albuterol Sulfate Hfa	Albuterol Sulfate	93	23
Metoprolol Succinate	Metoprolol Succinate	91	22
Alprazolam	Alprazolam	90	19
Sertraline Hcl	Sertraline Hcl	86	18
Potassium Chloride	Potassium Chloride	84	17
Carvedilol	Carvedilol	83	23
Donepezil Hcl	Donepezil Hcl	75	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	68	17
Azithromycin	Azithromycin	64	50
Fluticasone Propionate	Fluticasone Propionate	64	19
Latanoprost	Latanoprost	64	suppressed
Memantine Hcl	Memantine Hcl	59	11
Hydralazine Hcl	Hydralazine Hcl	58	suppressed
Prednisone	Prednisone	58	34
Farxiga	Dapagliflozin Propanediol	55	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	54	13
Diclofenac Sodium	Diclofenac Sodium	53	21
Pantoprazole Sodium	Pantoprazole Sodium	53	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	50	33
Glimepiride	Glimepiride	50	13
Duloxetine Hcl	Duloxetine Hcl	49	12
Finasteride	Finasteride	49	suppressed
Glipizide	Glipizide	49	suppressed
Clopidogrel	Clopidogrel Bisulfate	48	12
Carbidopa-Levodopa	Carbidopa/Levodopa	47	suppressed
Mirtazapine	Mirtazapine	47	11
Hydrochlorothiazide	Hydrochlorothiazide	46	13
Montelukast Sodium	Montelukast Sodium	46	11
Allopurinol	Allopurinol	45	12
Bupropion Xl	Bupropion Hcl	43	suppressed
Atenolol	Atenolol	42	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	41	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	30
Metformin Hcl Er	Metformin Hcl	38	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	37	suppressed
Meloxicam	Meloxicam	36	19
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	15
Januvia	Sitagliptin Phosphate	34	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Cephalexin	Cephalexin	33	20
Novolog	Insulin Aspart	33	suppressed
Spironolactone	Spironolactone	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	26
Buspirone Hcl	Buspirone Hcl	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Nifedipine Er	Nifedipine	32	13
Ozempic	Semaglutide	32	suppressed
Diazepam	Diazepam	30	suppressed
Nystatin	Nystatin	30	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Lorazepam	Lorazepam	28	suppressed
Divalproex Sodium	Divalproex Sodium	26	suppressed
Lidocaine	Lidocaine	26	suppressed
Desmopressin Acetate	Desmopressin Acetate	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Morphine Sulfate Er	Morphine Sulfate	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Celecoxib	Celecoxib	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Sotalol	Sotalol Hcl	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Amoxicillin	Amoxicillin	17	15
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Diltiazem Hcl	Diltiazem Hcl	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Benztropine Mesylate	Benztropine Mesylate	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	12
Olanzapine	Olanzapine	15	suppressed
Humalog	Insulin Lispro	14	suppressed
Klayesta	Nystatin	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	14	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	11
Carbamazepine Er	Carbamazepine	12	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Oxymorphone Hcl Er	Oxymorphone Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Silodosin	Silodosin	12	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Topiramate	Topiramate	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error